currence of new vertebral fractures and serious adverse events was not observed. Conclusions: Both RIS + VD3 (alfacalcidol) therapy and RIS + VK2 (menatetrenone) therapy increased the BMD and inhibited bone resorption similarly to RIS monotherapy in patients with primary osteoporosis. In this study, RIS + VK2 therapy was suggested to reduce the inhibition of bone formation compared with RIS monotherapy, and was thus considered to be more effective for improving bone strength.
. Concentration-dependent attachment of hCh-1 cells. Plates were coated with different concentration of proteins and hCh-1 cells were culture in the plate for adhesion assay. triplets in Exon 3-8 recombinant protein reduced cell attachment to insignificant levels. In addition, the synthetic peptide RGD, but not RAD, inhibited the ability of N-propeptide to promote cell attachment. GST pull-down assay showed that type IIB Npropeptide interacted with integrins αVβ3 and αVβ5, but not α1β1, α5β1 or α3β1. The integrin-mediated interaction induced actin polymerization and subsequent internalization of N-propeptides of both type IIA and IIB. Although the endocytosis of both IIA and IIB N-propeptides occurred, there are differences in the intracellular localization patterns between these spliced forms (Fig. 2) . The binding of N-propeptides also induced internalization of integrin beta3, indicating that the integrin-dependent cell adhesion to the type II collagen N-propeptides promotes integrin recycling. Conclusions: Our data show for the first time that the collagen N-propeptide functions in cell signaling. This RGD-dependent signaling is clearly functionally different from the fibrillar collagen binding to α1β1, α2β1, α10β1 and α11β1 integrins that do not bind RGD. Endocytosis of both IIA and IIB N-propeptides occurred after their binding to the cell surface. The integrin β3 was also internalized following the binding of N-propeptide to cell surface, suggesting that the integrin-dependent cell adhesion to the Type II collagen N-propeptides may trigger the signaling machinery involved in integrin recycling. Overall, the ability of the type II procollagen N-propeptides to bind, internalize and signal via integrins could be a critical biological function for correct development of collagen tissue. Purpose: In this study we i) followed Notch-1 protein levels in human mesenchymal stem cells (hMSC) pellet cultures and ii) tested the hypothesis that commonly employed pro-chondrogenic factors (TGFb3, BMP6, dexamethasone) aid in the suppression of Notch protein levels in hMSC and adult human articular chondrocytes (AHAC). Methods: Cell source: hMSC were derived from bone marrow aspirates (approval by human subjects committee). AHAC were isolated via collagenase digestion. Pellet cultures: Each hMSC pellet was made with 2.5x105 cells in 15ml polypropylene tubes with chondrogenic medium (Cambrex) supplemented with 10ng/ml TGFb3 (Cambrex) and 500 ng/ml BMP6 (R&D Systems). Medium changes were made every 2-3 days. Pellets were harvested for western blotting and RT-PCR on days 2, 4, 8 and 14. RT-PCR: RNA was extracted from pellets using an RNeasy kit (Qiagen). Gene expression levels of collagen type II and type X were assessed. Monolayer studies: hMSC and AHAC were seeded in 6 well plates at a density of 2.5x105 per well and exposed to BMP6 (500ng/ml), TGFb3 (10ng/ml), dexamethasone (Dex 10-8M), Dex+TGFb3 and control base medium (DMEM plus 10% Calf serum) for 4, 12, 24 and 72 hours. Western blotting: Pellets and monolayer cells were lysed and loaded on 6% Tris-Glycine gels (Invitrogen) and transferred to nitrocellulose. Notch-1 antibody (rat anti human; bTAN20, Hybridoma Bank) was used to detect the Notch-1 intracellular domain (NICD). Secondary goat anti-rat HRP conjugated antibody (Santa Cruz) was used to detect NICD. Mouse anti-human GAPDH was used to ensure equal loading. Results: Notch-1 during chondrogenesis: Reduction of Notch-1 was noted by day 4 of hMSC pellet culture and was almost not detectable by day 8. Although, NICD protein levels returned by day 14. Collagen type II and type X were detected by day 4 and continued to increase by day 14 (>100-fold compared to monolayer). Notch-1 and prochondrogenic factors: Monolayer culture of both AHAC and hMSC in the presence of TGFb3 led to a reduction in Notch-1 protein levels after 72 hours. No detectable alteration in NICD was found with BMP6 or Dex. Conclusions: Reduction of Notch-1 is required to allow chondrogensis and this preliminary data suggest that TGFb3 mediates this process. The mechanism may due to increased proteosome degradation or RNA instability. Notch-1 re-expression by day 14 parallels collagen type X up-regulation, which is consistent with Notch's dual role in mediating chondrogenesis and osteogenesis. Understanding of transcription regulatory pathways mediated by Notch will be needed if these cells are to be used successfully in cell-based cartilage repair, where phenotype stability is essential.
P127 TGFb3 MODULATES NOTCH-1 PROTEIN EXPRESSION LEVELS IN HUMAN ARTICULAR CHONDROCYTES AND MESENCHYMAL STEM CELLS

P128 INTERLEUKIN-1 BETA AND INTERLEUKIN-6 DISTURB THE ANTIOXIDANT ENZYME SYSTEM IN BOVINE CHONDROCYTES: A POSSIBLE EXPLANATION FOR OXIDATIVE STRESS GENERATION
M. Mathy-Hartert, L. Hogge, C. Sanchez, G. Deby-Dupont, Y. Henrotin University of Liège, Liège, Belgium Purpose: Beside matrix metalloproteinases, reactive oxygen species (ROS) are the main biochemical factors of cartilage degradation. Numerous soluble factors, including interleukin (IL)-1β and -6, stimulate ROS production by chondrocytes, and presumably induce an oxidative stress inside and in the vicinity of the cells. To prevent ROS toxicity, chondrocytes possess a well-coordinated antioxidant enzyme system mainly formed by superoxide dismutases (SOD) and catalase (Cat). This work was designed to assess the effects of IL-1β and IL-6 on the gene expression and enzymatic activity of SOD and Cat in bovine chondrocytes. Methods: Bovine chondrocytes were cultured in monolayer for 4 hours to 11 days in the absence or in the presence of to 10 -10 M) or IL-6 (10 to 100 ng/ml). To study signal transduction pathway, inhibitors of mitogen-activated protein kinases (MAPK) (PD98059, SB203580, SP600125) (5 to 20 μM) and NF-κB inhibitor (BAY11-7082 (1 to 5 μM), MG-132 (0.1 to 10 μM)) were used. SOD and Cat enzymatic activities were evaluated in cellular extract by using respectively the SOD Assay Kit-WST (Dojindo Molecular Technologies) and the Amplex Red Catalase Assay (Molecular Probes). Cu/Zn SOD, Mn SOD and Cat gene expressions were quantified by reverse transcription of mRNA followed by real time and quantitative polymerase chain reaction. Results: SOD activity was dose and time dependently increased by IL-1β, but not by IL-6. Further, IL-1β markedly enhanced Mn SOD gene expression, but slightly decreased Cu/Zn SOD gene expression. IL-1β-stimulated SOD enzymatic activity and Mn SOD mRNA expression were inhibited by NF-κB inhibitors but not by MAPK inhibitors. IL-6 did not significantly modified SOD mRNA levels. After 1 day of incubation, Cat gene expression was significantly downregulated by IL-1β and IL-6. NF-kB and MAPK inhibitors did not affect the IL-1β inhibitory effect. In parallel, after 5 days of incubation, IL-6 and IL-1β decreased Cat activity.
Conclusions:
We have demonstrated that IL-1β disturbs the antioxidant enzyme system in chondrocytes. This cytokine induces a rapid increase of Mn SOD production and a decrease of catalase synthesis. The imbalance between SOD and catalase could result in H 2 O 2 accumulation, and generate intracellularly an oxidative stress. To reinforce the antioxidant defences of chondrocytes should be considered in the management of osteoarthritis.
